LACTERA Therapeutics, Inc. is a Delaware C-Corporation built to connect biotechnology, clinical integrity and international business development. Our operating model is designed to translate protected innovation into responsible, globally relevant healthcare solutions.

Business provides the infrastructure for strategic partnerships, capital formation and international commercialization. Technology advances proprietary biotechnology, bioactive-material expertise and intellectual-property strategy. Medicine grounds development in clinical relevance, research discipline and patient outcomes.

Our principles are scientific excellence, patient-centred innovation, clinical integrity, global collaboration and long-term sustainability.